iBB

Diogo Silva will be defending his PhD thesis in Bioengineering (Cell Therapies and Regenerative Medicine) at Instituto Superior Técnico, wednesday the 17th October 2018 (9:00 H, room 4.41). During the last years, and under the supervision of Joaquim Cabral from SCERG-iBB and Manuel Abecasis from IPO, Diogo developed new Chimeric Antigen Receptors (CARs) for various types of hematologic cancers and optimized existing CARs that are already in the clinic. The title of his thesis is "Engineering of T-Cells with Chimeric Antigen Receptors as a Therapy for Hematologic Cancers”.